Product Information

FLUTICASONE PROP 0.005% OINT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.4399 per GM under NDC 45802022111. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on May 14, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FLUTICASONE PROP 0.005% OINT

Fluticasone Propionate
$0.4399per GM

Strength

.05 mg/g

NDC

45802022111

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

FLUTICASONE PROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076668

FDA Approved

5/14/2004

TE Code

AB

On Market Since

7/9/2007

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for FLUTICASONE PROP 0.005% OINT has been published 677 times since Nov 28, 2013, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4399 per GM
All-time high$0.6137 (Mar 15, 2017)
All-time low$0.3209 (Nov 17, 2021)
52-week high$0.5723
52-week low$0.4294
Median price$0.4551
Average price$0.4613
Largest weekly change+47.2% (Dec 22, 2021)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+1.7%

3M

+2.4%

6M

-22.7%

1Y

-0.2%

3Y

+0.4%

5Y

+37.1%

All

+2.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FLUTICASONE PROP 0.005% OINT?

The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE PROP 0.005% OINT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.4399 per GM (NDC 45802022111), effective Nov 11, 2026.

How has the price of FLUTICASONE PROP 0.005% OINT changed over time?

Over the history we have for it, the NADAC for FLUTICASONE PROP 0.005% OINT has risen 2.7%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for FLUTICASONE PROP 0.005% OINT?

Since Nov 28, 2013, the NADAC for FLUTICASONE PROP 0.005% OINT has ranged from a low of $0.3209 (Nov 17, 2021) to a high of $0.6137 (Mar 15, 2017), with a median of $0.4551 per GM.

Are there cheaper alternatives to FLUTICASONE PROP 0.005% OINT?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE PROP 0.005% OINT, is $0.3707 per GM — about 16% below FLUTICASONE PROP 0.005% OINT.

Who manufactures FLUTICASONE PROP 0.005% OINT?

FLUTICASONE PROP 0.005% OINT (NDC 45802022111) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.